NAMS fundamentals
An in-depth look to NewAmsterdam Pharma Company N.V. operating, investing, and financing activities
NAMS free cash flow for Q3 24 is -12.58 M USD. For 2023, NAMS free cash flow was -141.24 M USD and operating cash flow was -141.22 M USD.
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q1 '24
Q2 '24
Q3 '24
TTM